Establishment of pharmaceutical care model for lower extremity artery disease based on patients'disease self-management ability
OBJECTIVE To construct the integrated pharmaceutical care model of in-hospital pharmaceutical care+out-hospital pharmacy outpatient service for patients with lower extremity artery disease(LEAD),so as to improve patients'disease self-management ability,and the efficacy and safety of therapy.METHODS The in-hospital pharmaceutical care and out-hospital pharmacy outpatient service model was constructed for LEAD patients,including pharmaceutical evaluation,self-management ability education,and pharmacy follow-up,to perform long-term management of patients.Totally 65 LEAD patients admitted to the vascular surgery department of our hospital,receiving pharmacist management,from September,2021 to December,2022 were selected as the study objects,and pharmacists conducted in-hospital pharmaceutical care+continuous out-patient management.The efficacy indicators,safety indicators,and patients's disease self-management ability indicators were compared before and after 3 months of pharmacist management.RESULTS After 3 months of pharmacists'participation in the management of 65 patients,Fontaine stage decreased in 55 patients,there was the significant difference in Fontaine stage before and after management(P＜0.001).The proportion of patients who completely followed the guidelines for medication increased from 63.1%to 96.9%;the incidence of small bleeding was reduced by 7.7%after pharmacists'management.The scores of Morisky medication compliance and patients'disease self-management ability were higher than 3 months ago(P＜0.001).Patient proportion with"good"medical satisfaction increased by 18.4%.CONCLUSIONS The in-hospital pharmaceutical care and out-hospital pharmacy outpatient service model of LEAD patients can effectively improve patients'disease self-management ability,and improve the efficacy and safety of therapy.
万方数据
维普
